QurAlis Corp
Pharmaceutical company · Cambridge, Massachusetts, United States
QurAlis Corp is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2016. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.1 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2025.
QurAlis at a glance
What does QurAlis do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1.1 million in total (2019 to 2020). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $20 million sold (2025).
Frequently asked questions about QurAlis
Where is QurAlis headquartered?
QurAlis Corp is headquartered in Cambridge, Massachusetts, United States.
What does QurAlis do?
QurAlis Corp is a pharmaceutical company.
When was QurAlis founded?
The earliest incorporation on record for QurAlis Corp is in 2016, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
- Agios Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.